GlassScriptPhysician profile
Manikyam Mutyala
NPI 1326068198
$5,996.42
in general payments reported to CMS, 2019-2025
25 companies · $892 in 2025
The $892 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $953 · 2020: $330 · 2021: $431 · 2022: $539 · 2023: $1,484 · 2024: $1,367 · 2025: $892.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,742.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,742.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,678.07 | 2019-2025 | 2d Helical - 35, Complex Helical - 18, Embold Fibered |
| Janssen Pharmaceuticals, INC | $753.31 | 2019-2024 | Xarelto |
| Medtronic, INC. | $704.37 | 2022-2025 | Endurant Iis, Heli-Fx Endoanchor System |
| Inari Medical, INC. | $684.65 | 2021-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Xeris Pharmaceuticals, INC. | $243.71 | 2024-2025 | Gvoke Hypopen |
| Shockwave Medical, INC | $181.37 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Smith+Nephew, INC. | $181.27 | 2019-2024 | Collagenase Santyl |
| Intuity Medical INC | $137.38 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.00 | 2024 | Jardiance |
| Abbott Laboratories | $125.00 | 2023 | Freestyle Libre 3 |
| Amgen INC. | $124.97 | 2024 | |
| Horizon Therapeutics Plc | $124.58 | 2023 | Tepezza |
| Acera Surgical, INC. | $121.31 | 2025 | Restrata Wound Matrix |
| Ascendis Pharma Endocrinology INC | $119.62 | 2025 | Yorvipath |
| Dexcom, INC. | $115.56 | 2025 | Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161) |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $111.29 | 2022 | |
| Angiodynamics, INC. | $109.31 | 2019 | |
| Endologix LLC | $97.43 | 2025 | Afx2 Bifurcated Endograft System, Torus Stent Graft System, Endocross Device |
| W. L. Gore & Associates, INC. | $86.07 | 2019 | |
| Convatec INC. | $61.00 | 2024 | |
| Pfizer INC. | $32.10 | 2022-2023 | |
| Stryker Corporation | $27.70 | 2025 | Clottriever Bold Catheter |
| Tactile Systems Technology INC | $19.68 | 2025 | Nimbl, Flexitouch Plus |
| Circassia INC. | $16.75 | 2019 | |
| Lemaitre Vascular, INC. | $14.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manikyam Mutyala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.